title: MicroRNAs and atherosclerosis: new actors for an old movie.
abstract: To date, cardiovascular diseases (CVDs) are the leading causes of morbidity and mortality worldwide. MicroRNAs (miRNAs) are endogenous, short, non-coding RNA sequences able to regulate gene expression principally at the post-transcriptional level. Initially, they were thought to be involved only in developmental timing of worms. Their involvement in human biology was recently discovered and many studies have been performed to demonstrate the role of miRNA in human cancer. Since the first observation in 2005 of their implication in cardiac biology, many studies have demonstrated their role in the genetic modulation of cardiovascular development and in cardiovascular diseases such as cardial remodeling and heart failure, cardiac arrhythmias, cardiac ischaemia, cardiac fibrosis, atherosclerosis and stroke. Thus, the aim of this review is to describe the role of miRNA in atherosclerosis development and evolution and to individuate their role as potential therapeutic target.
authors: European Center of Excellence on Atherosclerosis, Hypertension and Dyslipidemia, and Clinical Research Center - Center of Excellence on Aging (Ce.S.I.), G. d'Annunzio University, Chieti-Pescara, Italy.
authors: D
authors: D
authors: Santovito
authors: A
authors: A
authors: Mezzetti
authors: F
authors: F
authors: Cipollone
mesh_terms: D050197:Atherosclerosis / Q000235:genetics* / Q000503:physiopathology / Q000628:therapy; D005786:Gene Expression Regulation; D006801:Humans; D035683:MicroRNAs / Q000235:genetics* / Q000378:metabolism; D009206:Myocardium / Q000378:metabolism; D012323:RNA Processing, Post-Transcriptional
chemical_list: D035683:MicroRNAs